{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:30:34Z","timestamp":1782473434402,"version":"3.54.5"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010552","name":"Departament de Salut, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["SLT017\/20\/000114"],"award-info":[{"award-number":["SLT017\/20\/000114"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010552","name":"Departament de Salut, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["PRE2018\\u2013084480"],"award-info":[{"award-number":["PRE2018\\u2013084480"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["ZIA DA000493"],"award-info":[{"award-number":["ZIA DA000493"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001866","name":"Fonds National de la Recherche Luxembourg","doi-asserted-by":"publisher","award":["20\/15084569"],"award-info":[{"award-number":["20\/15084569"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2017SGR1604"],"award-info":[{"award-number":["2017SGR1604"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013248","name":"Family Process Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013248","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005910","name":"Albert Ellis Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005910","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011961","name":"College of Environmental Science and Forestry, State University of New York","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J Fox Foundation for Parkinson&apos;s Research","doi-asserted-by":"publisher","award":["MJFF-001051"],"award-info":[{"award-number":["MJFF-001051"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011017","name":"Luxembourg Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PID2019\\u2013109240RB-I00"],"award-info":[{"award-number":["PID2019\\u2013109240RB-I00"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PID2020\\u2013118511RB-I00"],"award-info":[{"award-number":["PID2020\\u2013118511RB-I00"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["BES-2017\\u2013081872"],"award-info":[{"award-number":["BES-2017\\u2013081872"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.biopha.2022.113896","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T20:19:05Z","timestamp":1666383545000},"page":"113896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["The ADORA1 mutation linked to early-onset Parkinson\u2019s disease alters adenosine A1-A2A receptor heteromer formation and function"],"prefix":"10.1016","volume":"156","author":[{"given":"Laura I.","family":"Sarasola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Llinas","family":"del Torrent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"P\u00e9rez-Ar\u00e9valo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Argerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil","family":"Casajuana-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Chevign\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Fern\u00e1ndez-Due\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0832-3739","authenticated-orcid":false,"given":"Francisco","family":"Ciruela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113896_bib1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.113896_bib2","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2022.113896_bib3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.biopha.2022.113896_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2022.113896_bib5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1474-4422(06)70411-2","article-title":"Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism","volume":"5","author":"Schrag","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2022.113896_bib6","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/mds.26166","article-title":"Relationship of age of onset and family history in Parkinson disease","volume":"30","author":"Barrett","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2022.113896_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/cjn.2015.244","article-title":"Early-onset vs. Late-onset Parkinson\u2019s disease: A Clinical-pathological Study","volume":"43","author":"Ferguson","year":"2015","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.biopha.2022.113896_bib8","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1212\/WNL.0b013e31819908ce","article-title":"Treatments for Parkinson disease--past achievements and current clinical needs","volume":"72","author":"Poewe","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2022.113896_bib9","first-page":"S73","article-title":"Non-dopaminergic therapies","volume":"8","author":"Nutt","year":"2018","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.biopha.2022.113896_bib10","doi-asserted-by":"crossref","DOI":"10.2174\/187152711797247803","article-title":"An update on adenosine A2A receptors as drug target in Parkinson\u2019s Disease","volume":"10","author":"Vallano","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.biopha.2022.113896_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11302-020-09694-2","article-title":"The belated US FDA approval of the adenosine A 2A receptor antagonist istradefylline for treatment of Parkinson\u2019s disease","volume":"16","author":"Chen","year":"2020","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.biopha.2022.113896_bib12","first-page":"243","article-title":"Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A2A-Dopamine D2 Receptor Heterotetramers and Adenylyl Cyclase","volume":"9","author":"Ferr\u00e9","year":"2018"},{"key":"10.1016\/j.biopha.2022.113896_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107977","article-title":"G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs","volume":"231","author":"Ferr\u00e9","year":"2022","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2022.113896_bib14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/978-3-540-89615-9_16","article-title":"Adenosine receptors and the central nervous system","author":"Sebasti\u00e3o","year":"2009","journal-title":"Handb. Exp. Pharm."},{"key":"10.1016\/j.biopha.2022.113896_bib15","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1460-9568.1996.tb01617.x","article-title":"Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms","volume":"8","author":"Ferr\u00e9","year":"1996","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.biopha.2022.113896_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1471-4159.2006.04386.x","article-title":"Differential glutamate-dependent and glutamate-independent adenosine A1 receptor-mediated modulation of dopamine release in different striatal compartments","volume":"101","author":"Borycz","year":"2007","journal-title":"J. Neurochem"},{"key":"10.1016\/j.biopha.2022.113896_bib17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0165-6147(00)01517-0","article-title":"Fine-tuning neuromodulation by adenosine","volume":"21","author":"Sebastiao","year":"2000","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.biopha.2022.113896_bib18","first-page":"1380","article-title":"Adenosine receptors and brain diseases: neuroprotection and neurodegeneration","volume":"2011","author":"Gomes","year":"1808","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2022.113896_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0074-7742(05)63007-3","article-title":"Adenosine and brain function","volume":"63","author":"Fredholm","year":"2005","journal-title":"Int Rev. Neurobiol."},{"key":"10.1016\/j.biopha.2022.113896_bib20","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1523\/JNEUROSCI.3574-05.2006","article-title":"Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers","volume":"26","author":"Ciruela","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2022.113896_bib21","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/bph.12970","article-title":"Presynaptic adenosine A 2A receptors dampen cannabinoid CB 1 receptor-mediated inhibition of corticostriatal glutamatergic transmission","volume":"172","author":"Ferreira","year":"2015","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2022.113896_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1601631","article-title":"Key role of the dopamine D4 receptor in the modulation of corticostriatal glutamatergic neurotransmission","volume":"3","author":"Bonaventura","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2022.113896_bib23","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ana.25104","article-title":"Targeting hypersensitive corticostriatal terminals in restless legs syndrome","volume":"82","author":"Yepes","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2022.113896_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/s12915-020-0739-0","article-title":"Control of glutamate release by complexes of adenosine and cannabinoid receptors","volume":"18","author":"K\u00f6falvi","year":"2020","journal-title":"BMC Biol."},{"key":"10.1016\/j.biopha.2022.113896_bib25","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1007\/s00018-006-6216-2","article-title":"Heterodimeric adenosine receptors: a device to regulate neurotransmitter release","volume":"63","author":"Ciruela","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2022.113896_bib26","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/mds.26627","article-title":"Mutation in ADORA1 identified as likely cause of early-onset parkinsonism and cognitive dysfunction","volume":"31","author":"Jaberi","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2022.113896_bib27","doi-asserted-by":"crossref","DOI":"10.1124\/molpharm.120.000003","article-title":"Functional impact of the G279S substitution in the adenosine A 1-receptor (A 1 R-G279S 7.44), a mutation associated with parkinson\u2019s disease","volume":"98","author":"Nasrollahi-Shirazi","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2022.113896_bib28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/mds.26886","article-title":"International Parkinson\u2019s Disease Genomics Consortium, ADORA1 mutations are not a common cause of Parkinson\u2019s disease and dementia with Lewy bodies","volume":"32","author":"Blauwendraat","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2022.113896_bib29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/mds.27126","article-title":"PTRHD1 and possibly ADORA1 mutations contribute to Parkinsonism with intellectual disability","volume":"33","author":"Elahi","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2022.113896_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature18966","article-title":"Structure of the adenosine A(2A) receptor bound to an engineered G protein","volume":"536","author":"Carpenter","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.113896_bib31","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1074\/jbc.RA118.001975","article-title":"Mini G protein probes for active G protein-coupled receptors (GPCRs) in live cells","volume":"293","author":"Wan","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.113896_bib32","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1021\/acsptsci.1c00006","article-title":"Proadrenomedullin N-Terminal 20 Peptides (PAMPs) Are Agonists of the Chemokine Scavenger Receptor ACKR3\/CXCR7","volume":"4","author":"Meyrath","year":"2021","journal-title":"ACS Pharm. Transl. Sci."},{"key":"10.1016\/j.biopha.2022.113896_bib33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/B978-0-12-418687-3.00018-5","article-title":"Transient mammalian cell transfection with polyethylenimine (PEI)","volume":"529","author":"Longo","year":"2013","journal-title":"Methods Enzym."},{"key":"10.1016\/j.biopha.2022.113896_bib34","doi-asserted-by":"crossref","DOI":"10.1006\/mcne.1999.0808","article-title":"Homer-1c\/Vesl-1L modulates the cell surface targeting of metabotropic glutamate receptor type 1\u03b1: Evidence for an anchoring function","volume":"15","author":"Ciruela","year":"2000","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.biopha.2022.113896_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4939-3064-7_2","article-title":"Co-immunoprecipitation from brain","volume":"110","author":"Morat\u00f3","year":"2016","journal-title":"Neuromethods"},{"key":"10.1016\/j.biopha.2022.113896_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25071532","article-title":"Design, Synthesis and Characterization of a New Series of Fluorescent Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulators","volume":"25","author":"Fern\u00e1ndez-Due\u00f1as","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2022.113896_bib37","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1074\/jbc.RA118.006231","article-title":"A dynamic and screening-compatible nanoluciferase-based complementation assay enables profiling of individual GPCR-G protein interactions","volume":"294","author":"Laschet","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.113896_bib38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/978-1-4939-3064-7_28","article-title":"Determination of GPCR-mediated cAMP accumulation in rat striatal synaptosomes","volume":"110","author":"Taura","year":"2016","journal-title":"Neuromethods"},{"key":"10.1016\/j.biopha.2022.113896_bib39","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.cell.2017.01.042","article-title":"Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype Selectivity","volume":"168","author":"Glukhova","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.113896_bib40","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1021\/acs.jmedchem.6b00653","article-title":"Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength","volume":"59","author":"Segala","year":"2016","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2022.113896_bib41","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11111","article-title":"Structure of the \u03b4-opioid receptor bound to naltrindole","volume":"485","author":"Granier","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.113896_bib42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12915-016-0247-4","article-title":"Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs","volume":"14","author":"Navarro","year":"2016","journal-title":"BMC Biol."},{"key":"10.1016\/j.biopha.2022.113896_bib43","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jcim.9b00269","article-title":"A simple-to-use, generalized workflow for membrane-protein-lipid-bilayer system building","volume":"59","author":"Schott-Verdugo","year":"2019","journal-title":"J. Chem. Inf. Model"},{"key":"10.1016\/j.biopha.2022.113896_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"2","author":"Abraham","year":"2015","journal-title":"SoftwareX 1"},{"key":"10.1016\/j.biopha.2022.113896_bib45","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.csbj.2020.09.028","article-title":"Experimental and computational analysis of biased agonism on full-length and a C-terminally truncated adenosine A 2A receptor","volume":"18","author":"Navarro","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.biopha.2022.113896_bib46","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/jcc.21787","article-title":"MDAnalysis: a toolkit for the analysis of molecular dynamics simulations","volume":"32","author":"Michaud-Agrawal","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.biopha.2022.113896_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-7-123","article-title":"Detecting outliers when fitting data with nonlinear regression - A new method based on robust nonlinear regression and the false discovery rate","volume":"7","author":"Motulsky","year":"2006","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.biopha.2022.113896_bib48","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/s41594-021-00674-7","article-title":"GPCR activation mechanisms across classes and macro\/microscales","volume":"28","author":"Hauser","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.biopha.2022.113896_bib49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tips.2017.11.001","article-title":"Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms","volume":"39","author":"Jespers","year":"2018","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.biopha.2022.113896_bib50","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1146\/annurev-biochem-060614-033910","article-title":"The Molecular Basis of G Protein-Coupled Receptor Activation","volume":"87","author":"Weis","year":"2018","journal-title":"Annu Rev. Biochem"},{"key":"10.1016\/j.biopha.2022.113896_bib51","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/sj.bjp.0705577","article-title":"An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors","volume":"140","author":"Savinainen","year":"2003","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2022.113896_bib52","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.biochem.7b01197","article-title":"Glycine Perturbs Local and Global Conformational Flexibility of a Transmembrane Helix","volume":"57","author":"H\u00f6gel","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2022.113896_bib53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0006-3495(04)74088-6","article-title":"Ser and Thr residues modulate the conformation of pro-kinked transmembrane alpha-helices","volume":"86","author":"Deupi","year":"2004","journal-title":"Biophys. J."},{"key":"10.1016\/j.biopha.2022.113896_bib54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jsb.2009.09.009","article-title":"Influence of the g- conformation of Ser and Thr on the structure of transmembrane helices","volume":"169","author":"Deupi","year":"2010","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.biopha.2022.113896_bib55","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.3390\/molecules27123742","article-title":"Cancer-Related Somatic Mutations in Transmembrane Helices Alter Adenosine A1 Receptor Pharmacology","volume":"27","author":"Wang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2022.113896_bib56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cbic.200600429","article-title":"The role of internal water molecules in the structure and function of the rhodopsin family of G protein-coupled receptors","volume":"8","author":"Pardo","year":"2007","journal-title":"Chembiochem"},{"key":"10.1016\/j.biopha.2022.113896_bib57","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1021\/acs.jcim.8b00924","article-title":"Mechanisms Underlying Allosteric Molecular Switches of Metabotropic Glutamate Receptor 5","volume":"59","author":"Llinas Del Torrent","year":"2019","journal-title":"J. Chem. Inf. Model"},{"key":"10.1016\/j.biopha.2022.113896_bib58","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1073\/pnas.1809251116","article-title":"Diverse GPCRs exhibit conserved water networks for stabilization and activation","volume":"116","author":"Venkatakrishnan","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.113896_bib59","doi-asserted-by":"crossref","DOI":"10.1186\/s12915-018-0491-x","article-title":"Cross-communication between G i and G s in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain","volume":"16","author":"Navarro","year":"2018","journal-title":"BMC Biol."},{"key":"10.1016\/j.biopha.2022.113896_bib60","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1007\/s00018-021-03761-6","article-title":"Structure and function of adenosine receptor heteromers","volume":"78","author":"Franco","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2022.113896_bib61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1124\/pharmrev.120.000011","article-title":"Mutations in G protein-coupled receptors: mechanisms, pathophysiology and potential therapeutic approaches","volume":"73","author":"Sch\u00f6neberg","year":"2021","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.biopha.2022.113896_bib62","doi-asserted-by":"crossref","first-page":"D335","DOI":"10.1093\/nar\/gkaa1080","article-title":"GPCRdb in 2021: integrating GPCR sequence, structure and function","volume":"49","author":"Kooistra","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2022.113896_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27051489","article-title":"Brain iron deficiency changes the stoichiometry of adenosine receptor subtypes in cortico-striatal terminals: implications for restless legs syndrome","volume":"27","author":"Rodrigues","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2022.113896_bib64","first-page":"3","article-title":"Adenosine mechanisms and hypersensitive corticostriatal terminals in restless legs syndrome","volume":"84","author":"Ferr\u00e9","year":"2019","journal-title":"Ration. Use Inhib. Aden Transp., Adv. Pharm."},{"key":"10.1016\/j.biopha.2022.113896_bib65","first-page":"9","article-title":"Adenosine receptors interacting proteins (ARIPs): Behind the biology of adenosine signaling","volume":"2010","author":"Ciruela","year":"1798","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2022.113896_bib66","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41586-018-0236-6","article-title":"Structure of the adenosine-bound human adenosine A1 receptor-Gi complex","volume":"558","author":"Draper-Joyce","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.113896_bib67","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/jnr.490420610","article-title":"Immunological identification of A1 adenosine receptors in brain cortex","volume":"42","author":"Ciruela","year":"1995","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.biopha.2022.113896_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat7052","article-title":"Crystal structure of rhodopsin in complex with a mini-G o sheds light on the principles of G protein selectivity","volume":"4","author":"Tsai","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2022.113896_bib69","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/bioinformatics\/btk023","article-title":"OPM: orientations of proteins in membranes database","volume":"22","author":"Lomize","year":"2006","journal-title":"Bioinformatics"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222012859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222012859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:28:27Z","timestamp":1778754507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222012859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":69,"alternative-id":["S0753332222012859"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113896","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ADORA1 mutation linked to early-onset Parkinson\u2019s disease alters adenosine A1-A2A receptor heteromer formation and function","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113896","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113896"}}